{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:32:31Z","timestamp":1793017951882,"version":"4.5.0"},"reference-count":34,"publisher":"Korean Stroke Society","issue":"2","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["j-stroke.org"],"crossmark-restriction":true},"short-container-title":["J Stroke"],"published-print":{"date-parts":[[2026,5,31]]},"abstract":"<jats:p>Patients with atrial fibrillation who experience acute ischemic stroke (AIS) are at high risk of early recurrent ischemic stroke or systemic embolism. Timely initiation of anticoagulation is essential to prevent subsequent ischemic events but must be carefully balanced against the risk of hemorrhagic transformation or intracranial hemorrhage. Historically, early anticoagulation therapy with heparin or vitamin K antagonists for AIS has shown uncertain benefits. The safety and efficacy of early initiation of non-vitamin K oral anticoagulants, initially suggested by observational studies, have been confirmed by randomized controlled trials and further supported by an individual patient data meta-analysis. However, uncertainties remain in specific populations, including those with severe stroke, hemorrhagic transformation, and Asian patients, who are at an increased risk of intracranial bleeding and are underrepresented in clinical trials.<\/jats:p>","DOI":"10.5853\/jos.2025.05211","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:10:11Z","timestamp":1776903011000},"page":"193-200","update-policy":"https:\/\/doi.org\/10.5853\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early Anticoagulation in Acute Ischemic Stroke With Atrial Fibrillation"],"prefix":"10.5853","volume":"28","author":[{"given":"Hong-Kyun","family":"Park","sequence":"first","affiliation":[{"name":"Department of Neurology, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-6111","authenticated-orcid":true,"given":"Keun-Sik","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3882","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.14.5.688"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2345"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(97)04011-7"},{"key":"ref4","first-page":"1139","volume-title":"Dabigatran versus warfarin in patients with atrial fibrillation","author":"Connolly","year":"2009"},{"key":"ref5","first-page":"981","volume-title":"Apixaban versus warfarin in patients with atrial fibrillation","author":"Granger","year":"2011"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1009638"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1310907"},{"key":"ref8","first-page":"1612","volume-title":"2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","author":"Steffel","year":"2021"},{"key":"ref9","first-page":"e364","volume-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","author":"Kleindorfer","year":"2021"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.122.060666"},{"key":"ref11","first-page":"2411","volume-title":"Early versus later anticoagulation for stroke with atrial fibrillation","author":"Fischer","year":"2023"},{"key":"ref12","first-page":"1731","volume-title":"Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial","author":"Werring","year":"2024"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.0285"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(25)00439-8"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92358-z"},{"key":"ref16","first-page":"2175","volume-title":"Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study","author":"Paciaroni","year":"2015"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318890"},{"key":"ref18","first-page":"539","volume-title":"Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study","author":"Wilson","year":"2018"},{"key":"ref19","first-page":"1139","volume-title":"Dabigatran versus warfarin in patients with atrial fibrillation","author":"Connolly","year":"2009"},{"key":"ref20","first-page":"981","volume-title":"Apixaban versus warfarin in patients with atrial fibrillation","author":"Granger","year":"2011"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1009638"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1310907"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/1747493016632239"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-18-0067"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.2161"},{"key":"ref26","first-page":"823","volume-title":"Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation","author":"Seiffge","year":"2019"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/17474930231184366"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/23969873241242239"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.119.028118"},{"key":"ref30","first-page":"1540","volume-title":"Practical \u201c1-2-3-4-day\u201d rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation: combined hospital-based cohort study","author":"Kimura","year":"2022"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2023.00325"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108371"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/23969873241251931"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.124.069324"}],"container-title":["Journal of Stroke"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/j-stroke.org\/upload\/pdf\/jos-2025-05211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/j-stroke.org\/journal\/view.php?doi=10.5853\/jos.2025.05211","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/j-stroke.org\/upload\/pdf\/jos-2025-05211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:52:15Z","timestamp":1780379535000},"score":1,"resource":{"primary":{"URL":"http:\/\/j-stroke.org\/journal\/view.php?doi=10.5853\/jos.2025.05211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"URL":"https:\/\/doi.org\/10.5853\/jos.2025.05211","relation":{},"ISSN":["2287-6391","2287-6405"],"issn-type":[{"value":"2287-6391","type":"print"},{"value":"2287-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]},"assertion":[{"value":"2025-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-31","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}